Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1967]

T cells engineered with chimeric antigen receptor targeting CD19 produce...

Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA

T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence ( Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )

Removal of alpha/beta T cells and of CD19 B cells in children With acute...

Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy

Removal of alpha/beta T cells and of CD19 B cells in children With acute leukaemia ( Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy )

Transplantation and short telomeres increase the risk of cognitive impairment

Dr Smita Bhatia - City of Hope National Medical Center, Duarte, California

Transplantation and short telomeres increase the risk of cognitive impairment ( Dr Smita Bhatia - City of Hope National Medical Center, Duarte, California )

Study of the efficacy and safety of siltuximab, an anti-interleukin-6...

Dr Raymond Wong - Chinese University of Hong Kong

Study of the efficacy and safety of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with multicentric Castleman’s disease ( Dr Raymond Wong - Chinese University of Hong Kong )

Results from the randomised phase III Children’s Oncology Group (COG) trial...

Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA

Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531 ( Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA )

Final stage II results of the CLL11 trial

Dr Valentin Goede - University of Cologne, Germany

Final stage II results of the CLL11 trial ( Dr Valentin Goede - University of Cologne, Germany )

Donor-derived anti-CD19 chimeric-antigen-receptor-expressing T cells cause...

Dr James Kochenderfer - National Cancer Institute, Bethesda, USA

Donor-derived anti-CD19 chimeric-antigen-receptor-expressing T cells cause regression of malignancy ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )

Equality of access to transplant for ethnic minority patients

Dr Robert Lown - University College London, UK

Equality of access to transplant for ethnic minority patients ( Dr Robert Lown - University College London, UK )

Effective treatment of chemotherapy-refractory diffuse large B cell lymphoma

Dr James Kochenderfer - National Cancer Institute, Bethesda, USA

$Effective treatment of chemotherapy-refractory diffuse large B cell lymphoma ( Dr James Kochenderfer - National Cancer Institute, Bethesda, USA )$

Encouraging outcomes in older patients following nonmyeloablative...

Dr Yvette Kasamon - Johns Hopkins Kimmel Cancer Center, Baltimore, USA

Encouraging outcomes in older patients following nonmyeloablative haploidentical blood or marrow transplantation ( Dr Yvette Kasamon - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )

Immune reconstitution and preliminary safety analysis of somatic gene therapy

Dr Sung-Yun Pai - Harvard Medical School, Boston, USA

Immune reconstitution and preliminary safety analysis of somatic gene therapy ( Dr Sung-Yun Pai - Harvard Medical School, Boston, USA )

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome...

Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The...

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction ( Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands )

More from ecancer